Cutiss
Phase 2CUTISS is the only late-stage clinical TechBio company developing skin tissue therapeutics and dedicated to bioengineering. We are transforming skin surgery with denovoSkin™, our first-in-class personalized tissue therapy that enables automated, on-demand production of living skin at scale.
Founded
2017
Focus
Biologics
About
CUTISS is the only late-stage clinical TechBio company developing skin tissue therapeutics and dedicated to bioengineering. We are transforming skin surgery with denovoSkin™, our first-in-class personalized tissue therapy that enables automated, on-demand production of living skin at scale.
Funding History
2Total raised: $65M
Series B$50MEVA Growth FundMar 15, 2022
Series A$15MGimvSep 15, 2020
Company Info
TypePrivate
Founded2017
LocationZurich, Switzerland
StagePhase 2
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile